Subscribe
23 May 2018Americas

DowDuPont unit and Monsanto sign insect licensing deal

Corteva Agriscience, the agriculture division of DowDuPont, has signed a licensing deal with Monsanto to use its technology for fighting insects found on corn.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Bayer makes $62bn Monsanto bid
24 May 2016   Pharmaceutical company Bayer has revealed that it is offering to buy Monsanto for $62 billion.
Americas
Monsanto enters into CRISPR/Cas licensing deal
28 September 2016   Agrochemical company Monsanto has entered into a global licensing agreement with the Broad Institute of MIT and Harvard to use the CRISPR/Cas genome-editing technology in agriculture.
Americas
Bayer-Monsanto deal: US gov orders largest-ever merger divestiture
30 May 2018   The US government has required German company Bayer to divest $9 billion worth of business and assets in order to continue with its proposed $66 billion acquisition of US-based Monsanto.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Big Pharma
Bayer makes $62bn Monsanto bid
24 May 2016   Pharmaceutical company Bayer has revealed that it is offering to buy Monsanto for $62 billion.
Americas
Monsanto enters into CRISPR/Cas licensing deal
28 September 2016   Agrochemical company Monsanto has entered into a global licensing agreement with the Broad Institute of MIT and Harvard to use the CRISPR/Cas genome-editing technology in agriculture.
Americas
Bayer-Monsanto deal: US gov orders largest-ever merger divestiture
30 May 2018   The US government has required German company Bayer to divest $9 billion worth of business and assets in order to continue with its proposed $66 billion acquisition of US-based Monsanto.

More on this story

Big Pharma
Bayer makes $62bn Monsanto bid
24 May 2016   Pharmaceutical company Bayer has revealed that it is offering to buy Monsanto for $62 billion.
Americas
Monsanto enters into CRISPR/Cas licensing deal
28 September 2016   Agrochemical company Monsanto has entered into a global licensing agreement with the Broad Institute of MIT and Harvard to use the CRISPR/Cas genome-editing technology in agriculture.
Americas
Bayer-Monsanto deal: US gov orders largest-ever merger divestiture
30 May 2018   The US government has required German company Bayer to divest $9 billion worth of business and assets in order to continue with its proposed $66 billion acquisition of US-based Monsanto.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent